Degirmencay, Abdullah;
Thomas, Sharyn;
Holler, Angelika;
Burgess, Samuel;
Morris, Emma C;
Stauss, Hans J;
(2024)
Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell function.
Frontiers in Immunology
, 15
, Article 1386132. 10.3389/fimmu.2024.1386132.
Preview |
Text
Degirmencay_fimmu-15-1386132 (1).pdf Download (9MB) | Preview |
Abstract
The expression levels of TCRs on the surface of human T cells define the avidity of TCR-HLA/peptide interactions. In this study, we have explored which components of the TCR-CD3 complex are involved in determining the surface expression levels of TCRs in primary human T cells. The results show that there is a surplus of endogenous TCR α/β chains that can be mobilised by providing T cells with additional CD3γ,δ,ε,ζ chains, which leads to a 5-fold increase in TCR α/β surface expression. The analysis of individual CD3 chains revealed that provision of additional ζ chain alone was sufficient to achieve a 3-fold increase in endogenous TCR expression. Similarly, CD3ζ also limits the expression levels of exogenous TCRs transduced into primary human T cells. Interestingly, transduction with TCR plus CD3ζ not only increased surface expression of the introduced TCR, but it also reduced mispairing with endogenous TCR chains, resulting in improved antigen-specific function. TCR reconstitution experiments in HEK293T cells that do not express endogenous TCR or CD3 showed that TCRα/β and all four CD3 chains were required for optimal surface expression, while in the absence of CD3ζ the TCR expression was reduced by 50%. Together, the data show that CD3ζ is a key regulator of TCR expression levels in human T cells, and that gene transfer of exogenous TCR plus CD3ζ improved TCR surface expression, reduced TCR mispairing and increased antigen-specific function.
Type: | Article |
---|---|
Title: | Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell function |
Location: | Switzerland |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.3389/fimmu.2024.1386132 |
Publisher version: | https://doi.org/10.3389/fimmu.2024.1386132 |
Language: | English |
Additional information: | © 2024 Degirmencay, Thomas, Holler, Burgess, Morris and Stauss. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
Keywords: | TCR (T-cell receptor), TCR-T therapy, CD3-zeta, T cell function, TCR mispairing |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10199792 |
Archive Staff Only
![]() |
View Item |